What should be concerned in nanomedicine for the developing countries ?
10th International Conference on Nanomedicine and Nanotechnology in Health Care
July 25-27, 2016 Bangkok, Thailand

Viroj Wiwanitkit

Hainan Medical University, China
University of Nis, Serbia
Joseph Ayobabalola University, Nigeria
Dr DY Patil Medical University, India

Scientific Tracks Abstracts: J Nanomed Nanotechnol

Abstract:

Nanomedicine is the actual useful biomedical science at present. The usefulness of nanomedicine can be in either diagnosis, treatment and prevention. It is no doubt that the nanomedicine can become the worldwide issue. An interesting concern is on developing countries. The chance of the poor, developing countries to access new nanomedicine technology should be discussed. In addition, with the influx of new technology, assessment of effectiveness and safety is needed. With limitation of resource and knowledge, it seems developing countries can have risk for inequity in technology usage and also risk for uncontrolled quality of new coming nanomedicine tehnology and toxicity of new nanosubstance. Multidisciplinary collaboration to set global policies for management of the issue of present nanomedicine distribution in developing countries are needed.

Biography :

Viroj Wiwanitkit is an Asian Scholar. He is a visiitng professor of Hainan Medical University China; visiting professor, Faculty of Medicine, University of Nis, Serbia; adjunct professor, Joseph Ayobabalola University, Nigeria and; Honorary professor, Dr DY Patil Medical University, India. He has more than 2000 international publications. He has published more than 300 papers in reputed journals and has been serving as Editor and Ediorial Board Member of more than 50 international journals. His research interests include nanomedicine, tropical medicine and informatics.

Email: wviroj@yahoo.com